These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3806157)
1. Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer. Epenetos AA; Lavender JP; Kenemans P; Poels L J Clin Oncol; 1987 Jan; 5(1):160. PubMed ID: 3806157 [No Abstract] [Full Text] [Related]
2. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody imaging of colorectal and ovarian cancer. Haseman MK West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555 [No Abstract] [Full Text] [Related]
4. Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies. Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Corstens FH Eur J Obstet Gynecol Reprod Biol; 1991 Aug; 41(1):47-63. PubMed ID: 1748227 [No Abstract] [Full Text] [Related]
5. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]. Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855 [TBL] [Abstract][Full Text] [Related]
6. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy. Perkins AC; Pimm MV; Powell MC Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224 [TBL] [Abstract][Full Text] [Related]
8. Strategies for the development of monoclonal antibodies for in vivo imaging: their use in the imaging of ovarian carcinoma. Burchell J; Taylor-Papadimitriou J; Griffiths AB Cancer Detect Prev Suppl; 1987; 1():241-7. PubMed ID: 3480054 [TBL] [Abstract][Full Text] [Related]
9. The detection of ovarian cancer using 123J monoclonal antibody. Granowska M; Britton KE; Shepherd J Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079 [No Abstract] [Full Text] [Related]
10. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies. Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas. Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724 [TBL] [Abstract][Full Text] [Related]
13. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. Pimm MV; Perkins AC; Armitage NC; Baldwin RW J Nucl Med; 1985 Sep; 26(9):1011-23. PubMed ID: 3861794 [TBL] [Abstract][Full Text] [Related]
14. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients. Jusko WJ; Kung LP; Schmelter RF Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345 [No Abstract] [Full Text] [Related]
15. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings. Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499 [No Abstract] [Full Text] [Related]
16. Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3. Jobling TW; Granowska M; Britton KE; Lowe DG; Mather SJ; Burchell J; Naeem M; Shepherd JH Gynecol Oncol; 1990 Sep; 38(3):468-72. PubMed ID: 2227563 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose. van Hof AC; Molthoff CF; Davies Q; Perkins AC; Verheijen RH; Kenemans P; den Hollander W; Wilhelm AJ; Baker TS; Sopwith M; Frier M; Symonds EM; Roos JC Cancer Res; 1996 Nov; 56(22):5179-85. PubMed ID: 8912854 [TBL] [Abstract][Full Text] [Related]
18. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases]. Baum RP; Hertel A; Hör G Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623 [TBL] [Abstract][Full Text] [Related]
19. [Radioimmunodetection of cancer]. Itoh K; Nishi S; Hata Y Nihon Rinsho; 1986 Mar; 44(3):729-42. PubMed ID: 3525900 [No Abstract] [Full Text] [Related]
20. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Epenetos AA; Carr D; Johnson PM; Bodmer WF; Lavender JP Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]